Mural Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	109.23	271.11	0	0
Short-Term Investments	124.41	0	0	0
Cash & Cash Equivalents	233.64	271.11	0	0
Other Current Assets	5.79	6.23	4.82	4.24
Total Current Assets	239.43	277.34	4.82	4.24
Property, Plant & Equipment	22.03	24.15	28.93	30.87
Other Long-Term Assets	2.05	0.26	0	0
Total Long-Term Assets	24.08	24.41	28.93	30.87
Total Assets	263.5	301.75	33.75	35.11
Accounts Payable	1.57	5.97	2.97	10.59
Current Debt	6.16	6.1	5.84	5.92
Other Current Liabilities	13.52	16.95	32.75	16.74
Total Current Liabilities	21.25	29.02	41.56	33.25
Long-Term Debt	7.33	8.91	13.54	19.39
Other Long-Term Liabilities	0	0	0.3	0.36
Total Long-Term Liabilities	7.33	8.91	13.85	19.74
Total Liabilities	28.58	37.93	55.41	52.99
Total Debt	13.49	15.01	19.39	25.31
Debt Growth	-	-22.58%	-23.39%	-
Retained Earnings	-61.77	-30.86	0	-
Comprehensive Income	-0.07	0	0	0
Shareholders' Equity	234.93	263.82	-21.66	-17.88
Net Cash / Debt	220.16	256.1	-19.39	-25.31
Net Cash Per Share	-	15.34	-1.16	-
Working Capital	218.18	248.32	-36.74	-29.01
Book Value Per Share	13.99	15.81	-1.30	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).